# Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects

> **NCT02616445** · PHASE1 · COMPLETED · sponsor: **Actinogen Medical** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** UE2343
- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** UE2343
- **DRUG:** UE2343

## Key facts

- **NCT ID:** NCT02616445
- **Lead sponsor:** Actinogen Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-08
- **Final completion:** 2015-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02616445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02616445, "Phase I MAD, Fed-Fasted, CSF Study of UE2343 in Healthy Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02616445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*